FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search
Vol 6, No 1 (2013)


4-10 1123

In this paper gradually showed features of the methodology for conducting of pharmacoeconomics analysis of vaccination. Discribes criteria of selection of performance indicators for various vaccines. We performed accounts of costs associated with vaccination and also accounts and analysis of performance indicators

Russian Studies 

11-15 764

To provide pharmacoeconomic evaluation of diagnostics of tuberculosis infection (TI) with Allergen tuberculosis recombinant (CFP10-ESAT6) and Allergen tuberculosis purified liquid in the standard dilution for intradermal use (PPD RT 23 SSI). The «cost-effectiveness» analysis was provided. In the study direct costs were considered. Finally, total direct costs for the diagnostics one patient with active tuberculosis were 122.687 RUR, 3.646.833 RUR and 551.150 RUR, for the estimated diagnostic schemes, respectively. The pharmacoeconomic study results have shown, that a CFP10-ESAT6 is dominant technology from «cost-effectiveness» analysis perspective.


17-56 573

VII Congress with International Participation «Development of Pharmacoeconomics and Pharmacoepidemiology in Russian Federation»

ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)